Programmes.

AusMedtech, part of AusBiotech, is the national industry group for the medical devices and diagnostics sector in Australia.

Harnessing the rising opportunity in Asian biotechnology development and nurturing global engagement in established markets, including North America and Europe.

Information concerning biopharmaceuticals, biologics and biosimilars, personalised medicine, stem cell treatments and regenerative medicine. 

Clinical trials will play a pivotal role in the economy of the future, which will rely heavily on innovative jobs, exports and productivity.

Australia's Cell and Gene Catalyst seeks to create an end-to-end world-class value chain that can discover, develop, manufacture, and distribute cell and gene therapies to Australian patients, while creating jobs, commercialising research, and exporting Australian therapies to the world. 

Resources to support life sciences boards with best practice, regulation and corporate governance guides.

The AusBiotech-led Global Investment Programme aims to improve management and workforce skills.